Products
Our portfolio today consists of a line of oral CBD products designed to deliver dependable quality and safety to consumers. We offer immediate- and extended-release products in different strength amounts to give our customers the greatest flexibility and autonomy in dosing according to their individual needs.
Product Portfolio:
Immediate Release Tablets – 25, 50 and 100 mg dosages, available in 10- or 30-tablet cartons
Extended Release Tablets – 100 mg dosages, available in 10- or 30-tablet cartons

Product Pipeline
Asterra Labs is developing additional strengths of its immediate and modified release products. Asterra Labs is also investing in subsequent waves of products containing other cannabinoids and combination of cannabinoids in immediate and extended release presentations.
In addition to products for human consumption, Asterra labs is applying its same standards for rigor and control to a forthcoming line of veterinary products. We believe our pets deserve the same high quality we do.
Current Products
Asterra Labs' first wave of products will include the following:
| Immediate Release | 25 mg | 10 or 30 tablets |
| 50 mg | 10 or 30 tablets | |
| 100 mg | 10 or 30 tablets | |
| Extended Release | 100 mg | 10 or 30 tablets |
